University of Pittsburgh researchers have developed a comprehensive knowledgebase of molecular signatures of cancer driver genes and their impact on cancer immune responses. This innovative technology builds upon the previously disclosed Tumor-specific Driver Identification (TDI) framework, providing a detailed database of differentially expressed genes (DEGs) associated with driver somatic genome alterations (SGAs). The knowledgebase aims to guide molecularly targeted cancer therapy and immunotherapy, enhancing precision oncology practices.